TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting
TFF Pharmaceuticals, Inc. (TFFP)
Company Research
Source: Business Wire
Data presented on repurposing the existing, broad-spectrum antiviral agent using Thin Film Freezing and other techniques to enhance its effect for COVID-19 therapy AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced Dr. Robert O. Williams, inventor of the firm’s Thin Film Freezing technology, presented at the American Association of Pharmaceutical Scientists symposium on “COVID-19 - Current Pharmaceutical Developments for Cures and Prevention” on Tuesday, April 28. Dr. Williams and co-author Dr. Zachary N. Warnken presented data focusing on repurposing the existing antiviral drug, niclosamide, in a session titled, “Leveraging Repurposed Drugs – An Activity that Must be Exhausted.”Niclosamide is an oral anthelminthic drug, first approved by the US FDA for use in humans
Show less
Read more
Impact Snapshot
Event Time:
TFFP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TFFP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TFFP alerts
High impacting TFF Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
TFFP
News
- TFF Pharmaceuticals Announces It Will Wind Down OperationsGlobeNewswire
- TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why [Yahoo! Finance]Yahoo! Finance
- TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug DeliveryGlobeNewswire
- TFF Pharmaceuticals enters pact for dry powder mRNA-based Covid treatment [Seeking Alpha]Seeking Alpha
- TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVIDGlobeNewswire
TFFP
Sec Filings
- 11/20/24 - Form 10-Q
- 11/19/24 - Form SC
- 11/14/24 - Form NT
- TFFP's page on the SEC website